Published in J Clin Endocrinol Metab on March 17, 2010
Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor. Br J Pharmacol (2012) 1.04
Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor. Best Pract Res Clin Endocrinol Metab (2012) 1.03
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab (2012) 1.01
Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins. Clin Exp Immunol (2010) 0.96
Clinical review: Clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab (2013) 0.95
Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol (2013) 0.91
The role of thyrotrophin receptor antibody assays in graves' disease. J Thyroid Res (2012) 0.90
A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity. Clin Exp Immunol (2013) 0.86
Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto's thyroiditis and ophthalmopathy or isolated upper eyelid retraction. Clin Ophthalmol (2014) 0.86
Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. JAMA Ophthalmol (2015) 0.83
Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin. Eur Thyroid J (2015) 0.82
Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay. Eye (Lond) (2013) 0.81
Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease. Endocrinol Metab (Seoul) (2016) 0.80
Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathy. Yonsei Med J (2013) 0.80
TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis. J Clin Endocrinol Metab (2016) 0.79
TSH Receptor Antibody Functionality and Nomenclature. Front Endocrinol (Lausanne) (2017) 0.78
TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy. Nat Rev Endocrinol (2015) 0.78
Bioassays for TSH Receptor Antibodies: Quo Vadis? Eur Thyroid J (2015) 0.78
Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy. Yonsei Med J (2015) 0.77
Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy. Korean J Ophthalmol (2015) 0.77
News and views: at long last, an animal model of Graves' orbitopathy. Endocrinology (2013) 0.77
Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy. Turk J Ophthalmol (2015) 0.75
Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves' disease. Korean J Intern Med (2011) 0.75
Bioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor-LH/CG Receptor Chimeras: The Contribution of Leonard D. Kohn. Front Endocrinol (Lausanne) (2016) 0.75
Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor-guanine nucleotide-binding protein, (GNAS) fusion bioassay. Clin Exp Immunol (2012) 0.75
Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease. Int J Endocrinol (2016) 0.75
Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. Front Immunol (2017) 0.75
Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome. Science (1973) 2.74
Localization of D-lactate dehydrogenase in native and reconstituted Escherichia coli membrane vesicles. J Biol Chem (1975) 2.64
Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res (2001) 2.51
Genomic DNA released by dying cells induces the maturation of APCs. J Immunol (2001) 2.03
Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology (2000) 2.01
Procollagen peptidase: an enzyme excising the coordination peptides of procollagen. Proc Natl Acad Sci U S A (1971) 1.73
Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. Endocrinology (1977) 1.64
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab (2014) 1.63
Mechanisms of active transport in isolated bacterial membrane vesicles. XV. Purification and properties of the membrane-bound D-lactate dehydrogenase from Escherichia coli. J Biol Chem (1973) 1.60
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci U S A (1996) 1.56
Tetanus toxin interactions with thyroid plasma membranes. Implications for structure and function of tetanus toxin receptors and potential pathophysiological significance. J Biol Chem (1977) 1.53
Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease. Life Sci (1983) 1.48
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A (1999) 1.48
Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. Proc Natl Acad Sci U S A (1976) 1.48
Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. J Clin Endocrinol Metab (1993) 1.46
Integrated steady state rate equations and the determination of individual rate constants. J Biol Chem (1975) 1.45
The kinetic properties of spinach leaf glyoxylic acid reductase. J Biol Chem (1970) 1.44
The binding of thyrotropin to isolated bovine thyroid plasma membranes. J Biol Chem (1973) 1.43
Cloning and characterization of a cDNA that encodes a 70-kDa novel human thyroid autoantigen. J Biol Chem (1989) 1.41
The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid (2000) 1.40
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells. J Biol Chem (1997) 1.38
Thyrotropin effects on thyroid cells in culture. Effects of trypsin on the thyrotropin receptor and on thyrotropin-mediated cyclic 3':5'-AMP changes. J Biol Chem (1975) 1.37
Relationships of thyrotropin to exophthalmic-producing substance. Purification of homogeneous glycoproteins containing both activities from [3H]-labeled pituitary extracts. J Biol Chem (1970) 1.29
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology (1983) 1.29
Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab (2011) 1.28
Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion. J Biol Chem (1975) 1.24
Effects of thyrotropin on the thyroid cell membrane: hyperpolarization induced by hormone-receptor interaction. Proc Natl Acad Sci U S A (1977) 1.24
Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes. Proc Natl Acad Sci U S A (1976) 1.20
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol (2006) 1.19
Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies. N Engl J Med (1983) 1.19
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. Proc Natl Acad Sci U S A (1982) 1.18
Interaction of fragments B and C of tetanus toxin with neural and thyroid membranes and with gangliosides. J Biol Chem (1980) 1.18
Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells. J Biol Chem (1987) 1.16
Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. J Biol Chem (1975) 1.16
Calcium transport mechanisms in membrane vesicles from guinea pig brain synaptosomes. J Biol Chem (1981) 1.16
D-lactate dehydrogenase binding in Escherichia coli dld- membrane vesicles reconstituted for active transport. Proc Natl Acad Sci U S A (1974) 1.15
Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care (1998) 1.15
Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. Proc Natl Acad Sci U S A (1976) 1.14
Tryptophan residues of cholera toxin and its A and B protomers. Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1. J Biol Chem (1981) 1.14
Calf tendon procollagen peptidase: its purification and endopeptidase mode of action. Proc Natl Acad Sci U S A (1974) 1.14
Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun (1991) 1.13
Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A (2000) 1.13
Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science (1993) 1.13
Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci U S A (1998) 1.12
Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab (1986) 1.12
Sequence and chromosomal assignment of a novel cDNA identified by immunoscreening of a thyroid expression library: similarity to a family of mitochondrial solute carrier proteins. Mol Endocrinol (1989) 1.09
Structure-function studies of cholera toxin and its A and B protomers. Modification of tryptophan residues. J Biol Chem (1981) 1.09
Characteristics of a solubilized thyrotropin receptor from bovine thyroid plasma membranes. J Biol Chem (1975) 1.06
The structural properties of spinach leaf glyoxylic acid reductase. J Biol Chem (1970) 1.05
Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease. Proc Natl Acad Sci U S A (1981) 1.05
Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells. J Biol Chem (1985) 1.05
Characterization of fragment C and tetanus toxin binding to rat brain membranes. Mol Pharmacol (1981) 1.04
Relationships of the structure and function of the interferon receptor to hormone receptors and establishment of the antiviral state. Cancer Res (1978) 1.04
Effect of tetanus toxin on the accumulation of the permeant lipophilic cation tetraphenylphosphonium by guinea pig brain synaptosomes. Proc Natl Acad Sci U S A (1979) 1.03
The binding of ( 3 H)thyrotropin and an 3 H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue. Proc Natl Acad Sci U S A (1972) 1.03
Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling. Thyroid (2001) 1.02
Sequence similarity between cholera toxin and glycoprotein hormones: implications for structure activity relationship and mechanism of action. Biochem Biophys Res Commun (1976) 1.02
The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding. Endocrinology (1995) 1.01
Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1. Mol Endocrinol (1994) 1.01
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. Br J Ophthalmol (2008) 1.01
Tartaric acid metabolism. IV. Crystalline L-malic dehydrogenase from Pseudomonas acidovorans. J Biol Chem (1968) 1.00
Thyroid peroxidase: rat cDNA sequence, chromosomal localization in mouse, and regulation of gene expression by comparison to thyroglobulin in rat FRTL-5 cells. Mol Endocrinol (1989) 1.00
In vitro synthesis of procollagen on polysomes. Proc Natl Acad Sci U S A (1972) 1.00
Identification of thyroid transcription factor-1 in C cells and parathyroid cells. Endocrinology (1998) 0.99
Characterization of the 70KDA component of the human Ku autoantigen expressed in insect cell nuclei using a recombinant baculovirus vector. Biochem Biophys Res Commun (1990) 0.99
Structure of an exophthalmos-producing factor derived from thyrotropin by partial pepsin digestion. J Biol Chem (1975) 0.98
Thyroglobulin interactions with thyroid plasma membranes. The existence of specific receptors and their potential role. J Biol Chem (1979) 0.97
Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. Proc Natl Acad Sci U S A (1990) 0.97
Role of MHC class I molecules in autoimmune disease. Crit Rev Immunol (1997) 0.97
Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins. Clin Exp Immunol (2010) 0.96
Characteristics of a lysosomal membrane transport system for tyrosine and other neutral amino acids in rat thyroid cells. J Biol Chem (1986) 0.96
The contribution of subunits of thyroid stimulating hormone to the binding and biological activity of thyrotropin. Proc Natl Acad Sci U S A (1974) 0.96
Thyroid gangliosides with high affinity for thyrotropin: potential role in thyroid regulation. Science (1978) 0.95
Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology (1999) 0.95
A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab (1995) 0.95
Crystalline alpha2 beta2 complexes of tryptophan synthetase of Escherichia coli. A comparison between the native complex and the reconstituted complex. J Biol Chem (1974) 0.94
Cholera toxin inhibits interferon action. Biochem Biophys Res Commun (1976) 0.94
Thyrotropin receptor processing and interaction with thyrotropin. Biochem Biophys Res Commun (1990) 0.94
Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment. J Clin Endocrinol Metab (1996) 0.94
Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease. Ann N Y Acad Sci (1986) 0.93
Cell-free synthesis of procollagen: L-929 fibroblasts as a cellular model for dermatosparaxis. Proc Natl Acad Sci U S A (1973) 0.93
Role of phospholipids in the structure and function of the thyrotropin receptor. J Biol Chem (1979) 0.93
Thyroid transcription factor 1 is calcium modulated and coordinately regulates genes involved in calcium homeostasis in C cells. Mol Cell Biol (1998) 0.92
Tetanus toxin and thyrotropin interactions with rat brain membrane preparations. J Biol Chem (1979) 0.92
Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. Cardiovasc Res (1998) 0.91
Procollagen peptidase deficiency in a form of the Ehlers-Danlos syndrome. Trans Assoc Am Physicians (1973) 0.91
Tartaric acid metabolism. V. Crystalline tartrate dehydrogenase. J Biol Chem (1968) 0.91
Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. J Endocrinol Invest (1982) 0.91
A questionnaire survey on the management of Graves' orbitopathy in Europe. Eur J Endocrinol (2006) 0.91
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. J Clin Endocrinol Metab (1983) 0.90
Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab (1996) 0.90
Induction of autoimmunity by immunization of mice with human thyrotropin receptor. Cell Immunol (1994) 0.90
Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter. Mol Endocrinol (1992) 0.90